ONCOZ — Oncozenge AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK35.37m
- SEK25.71m
Annual cashflow statement for Oncozenge AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 29 W | 12 M | 12 M | 12 M |
| Source: | ARS | PRESS | ARS | ARS |
| Standards: | SAS | — | SAS | SAS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.801 | -4.89 | -43.6 | -15.9 |
| Non-Cash Items | 0 | 0 | 23.5 | 0 |
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.8 | 0.127 | -1.97 | -1.18 |
| Change in Accounts Receivable | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -0.001 | -4.77 | -22.1 | -17.1 |
| Other Investing Cash Flow Items | 0 | -5.36 | 0 | 0.57 |
| Change in Net Intangibles | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 0 | -5.36 | 0 | 0.57 |
| Financing Cash Flow Items | -0.5 | -8.74 | 0 | — |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Cash from Financing Activities | 10 | 51.3 | 0 | — |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 10 | 41.2 | -22.1 | -16.5 |